Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) is organized by EB Medicine.
Date of Original Release: June 1, 2019
Date of most recent review: May 15, 2019
Termination date: June 1, 2022
CME Expiration Date: July 1, 2022
This enduring material is designed for emergency medicine physicians, physician assistants, nurse practitioners, and residents.
4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits.
Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 2 Pharmacology CME credits
Many cases of anaphylaxis are misdiagnosed or undertreated. This issue offers guidance on the identification of patients with anaphylaxis, including those with atypical presentations, provides evidence-based recommendations for first- and second-line treatment, and discusses guidelines for patient disposition. You will learn:
• Clinical criteria for diagnosing patients with anaphylaxis
• Common causes of anaphylaxis
• Risk factors for biphasic reactions and fatal anaphylaxis
• Key historical questions and physical examination findings that help identify patients with anaphylaxis
• Which route of epinephrine administration is recommended and the appropriate dosing for pediatric patients
• When second-line treatments, such as antihistamines or corticosteroids, can be considered
• Guidelines for how long to observe patients in ED and • when patients should be admitted
• Appropriate disposition of patients with anaphylaxis, including prescribing epinephrine autoinjectors and offering training on how to use them, educating patients and families on avoidance of known offending allergens, and referring the patient to a specialist in allergy immunology
Upon completion of this activity, you should be able to:
(1) demonstrate medical decision-making based on the strongest clinical evidence;
(2) cost-effectively diagnose and treat the most critical presentations; and
(3) describe the most common medicolegal pitfalls for each topic covered.
Upon completion of this article, you should be able to:
• Recognize atypical presentations of anaphylaxis and identify risk factors for fatal anaphylaxis
• Differentiate other disease entities with signs and symptoms similar to anaphylaxis
• Administer first-line and/or second-line anaphylaxis treatment(s) according to recommendations in national guidelines
• Provide anticipatory discharge guidance and referral to appropriate follow-up care for patients with anaphylaxis
Pediatrics Allergy and Immunology